Saturday, July 11, 2026

Drug profile · INN

solithromycin

solithromycin (SOLITHROMYCIN TRISKEL EU SERVICES) is an FDA-listed pharmaceutical active ingredient.

EMA: application withdrawn Antiinfectives for systemic use (J01) J01FA
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — solithromycin
Class
Antiinfectives for systemic use (J01)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

solithromycin (SOLITHROMYCIN TRISKEL EU SERVICES) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN solithromycin
Brand SOLITHROMYCIN TRISKEL EU SERVICES
Therapeutic class Antiinfectives for systemic use (J01)
ATC code J01FA

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Frequently asked questions

What is solithromycin?

solithromycin (SOLITHROMYCIN TRISKEL EU SERVICES) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for solithromycin?

SOLITHROMYCIN TRISKEL EU SERVICES is a marketed brand name for solithromycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.